Revised SPC: Avastin (bevacizumab) 25mg/ml concentrate for solution for infusion

Source:
electronic Medicines Compendium - eMC
Publisher:
electronic Medicines compendium
Publication date:
08 October 2019

Abstract

Sections 4.4 and 4.8 advise use of VEGF pathway inhibitors in patients with or without hypertension may promote formation of aneurysms and/or artery dissections. This risk should be carefully considered in patients with risk factors such as hypertension or history of aneurysm.